Section Arrow
CDXS.NASDAQ
- Codexis
Quotes are at least 15-min delayed:2026/04/10 17:35 EDT
After Hours
Last
 2.22
-0.02 (-0.89%)
Bid
2.11
Ask
2.28
High 2.28 
Low 2.22 
Volume 181.44K 
Regular Hours (Closed)
Last
 2.24
-0.16 (-6.67%)
Day High 
2.46 
Prev. Close
2.4 
1-M High
2.45 
Volume 
1.71M 
Bid
2.11
Ask
2.28
Day Low
2.16 
Open
2.4 
1-M Low
1.18 
Market Cap 
218.09M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.84 
20-SMA 1.72 
50-SMA 1.41 
52-W High 3.87 
52-W Low 0.9583 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.50/-0.57
Enterprise Value
288.35M
Balance Sheet
Book Value Per Share
0.56
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
70.39M
Operating Revenue Per Share
0.81
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CUECue Biopharma0.5019+0.209+71.36%-- 
After Hours 0.4411 -0.0608 -12.11%
QNCXQuince Therapeutics0.1363+0.0126+10.19%-- 
After Hours 0.1211 -0.0152 -11.15%
VRAXVirax Biolabs Group Limited0.1041-0.0308-22.83%-- 
After Hours 0.1721 +0.068 +65.32%
ZNTLZentalis Pharmaceuticals6.61+2.19+49.55%-- 
After Hours 6.61 0 0.00%
IOVAIovance Biotherapeutics3.7-0.31-7.73%-- 
After Hours 3.7891 +0.0891 +2.41%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.